(Q51961342)

19 April 2018

title

Infrequency of "pure" GAD: impact of psychiatric comorbidity on clinical course. (English)

1 reference

19 April 2018

1 reference

2

1 reference

19 April 2018

author name string

S E Bruce

series ordinal

1

1 reference

19 April 2018

I Dyck

series ordinal

3

1 reference

19 April 2018

M B Keller

series ordinal

4

1 reference

19 April 2018

publication date

1 January 2001

1 reference

19 April 2018

published in

Depression and Anxiety

1 reference

19 April 2018

volume

14

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

page(s)

219-225

1 reference

19 April 2018

The natural history of anxiety disorders.

cites work

1 reference

The empirical basis of generalized anxiety disorder

21 January 2018

1 reference

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

21 January 2018

1 reference

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

21 January 2018

1 reference

Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey.

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

Factors predicting the clinical course of generalised anxiety disorder.

21 January 2018

1 reference

Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders

21 January 2018

1 reference

Co-morbidity and depression among the anxiety disorders. Issues in diagnosis and classification

21 January 2018

1 reference

The infrequency of "pure culture" diagnoses among the anxiety disorders.

21 January 2018

1 reference

Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).

21 January 2018

1 reference

Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up

21 January 2018

1 reference

Long-term follow-up of generalized anxiety disorder

21 January 2018

1 reference

Generalized anxiety disorder and its comorbidities: disputes at the boundaries.

21 January 2018

1 reference

Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group

21 January 2018

1 reference

Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders

21 January 2018

1 reference

Comorbidity among anxiety disorders: implications for treatment and DSM-IV.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DA.1070

1 reference

19 April 2018

1 reference

19 April 2018